GLENN TURNER: Open Payments
NPI 1073656203 · PLANT CITY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,110 in 152 payments from 24 companies in 2025. Trend: 2023 $3,269 · 2024 $3,385 · 2025 $3,110
Food & beverage: $3,110
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 23 | $629 |
| PFIZER INC. | 30 | $364 |
| ABBVIE INC. | 12 | $253 |
| Celgene Corporation | 10 | $228 |
| Novartis Pharmaceuticals Corporation | 17 | $214 |
| Teva Pharmaceuticals USA, Inc. | 10 | $206 |
| Janssen Biotech, Inc. | 6 | $174 |
| Lilly USA, LLC | 7 | $155 |
| Eisai Inc. | 7 | $150 |
| Neurocrine BioSciences, Inc. | 4 | $106 |
Products named: ZEPOSIA, NURTEC ODT, Briviact, KESIMPTA, AUSTEDO XR, Rystiggo, KISUNLA, Leqembi.
Industry payments across FL — which companies pay providers there.
